Ticker Details
Amarin Corporation plc Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health.
IPO Date:	April 1, 1993
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$315.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.16 | 3.50%
Avg Daily Range (30 D):	$0.21 | 1.43%
Avg Daily Range (90 D):	$0.33 | 2.25%

Institutional Daily Volume
Avg Daily Volume:	2.72M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	308
Avg Trade Size (Sh.) (30 D):	89
Avg Trade Size (Sh.) (90 D):	83

Institutional Trades
Total Institutional Trades:	4,737
Avg Institutional Trade:	$1.26M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$1.48M
Avg Closing Trade (30 D):	$1.18M
Avg Closing Trade (90 D):	$1.18M
Avg Closing Volume:	6.75K

News

Mar 7, 2026 @ 6:15 AM Here's Why I Wouldn't Touch Amarin With a 10â€â... Source: Reuben Gregg Brewer

Nov 11, 2025 @ 7:27 PM RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE ... Source: Recordati S.P.A.

Nov 9, 2025 @ 9:15 PM New REDUCE-IT® Aspirin Analysis Presented at AH... Source: Amarin Corporation

Oct 14, 2025 @ 12:00 PM Amarin and HLS Therapeutics Collaborate on Present... Source: Amarin Corporation

Mar 12, 2025 @ 11:01 AM Amarin Announces Plan to Initiate a Ratio Change U... Source: Amarin Corporation Plc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.08	$-.03	$
Diluted EPS	$-.08	$-.03	$
Revenue	$216.76M	$45.13M	$49.22M
Gross Profit	$113.51M	$17.77M	$23.17M
Net Income / Loss	$-33.61M	$-10.51M	$-1.22M
Operating Income / Loss	$-44.75M	$-11.33M	$-6.33M
Cost of Revenue	$103.25M	$27.36M	$26.05M
Net Cash Flow	$11.44M	$-3.6M	$11.76M
PE Ratio

Splits
Apr 11, 2025	1:20
Jan 18, 2008	1:10